Send the following on WhatsApp
Continue to Chat信標生物醫學與美國 City of Hope 癌症中心簽署全球獨家授權協議,用於胰管腺癌早期液體活檢篩查診斷的新型生物標誌物 https://geneonline.news/beacon-biomedical-signs-global-exclusive-deal-with-city-of-hope-for-early-pancreatic-cancer-liquid-biopsy-biomarkers/?variant=zh-cn